Financial ForecastsService revenue estimates for the coming years have been lowered and EPS forecasts have been revised downwards, indicating potential challenges to ISRG's profitability and growth.
Legal And Regulatory RisksThe District Court ruling that ISRG's da Vinci robot and EndoWrists are separate products could weaken ISRG's position in the pending antitrust lawsuit, potentially leading to significant financial consequences.
Product Launch And Supply Chain IssuesManagement's acknowledgment of potential choppiness in system placements due to DV5 supply constraints suggests that ISRG may face hurdles in meeting the market's demand, potentially affecting sales and revenue.